Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-007512
Filing Date
2014-02-18
Accepted
2014-02-18 21:17:06
Documents
2
Period of Report
2014-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 M. PERRY rrd402623.html 3  
1 FORM 3 M. PERRY rrd402623.xml 3 3529
2 POWER OF ATTORNEY rrd362362_410549.htm EX-24.TXT 3457
  Complete submission text file 0001181431-14-007512.txt   8498
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOTRANSPLANT INC 196 BOSTON AVE SUITE 2800 MEDFORD MA 02155
Business Address
PERRY MICHAEL S (Reporting) CIK: 0001250379 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23930 | Film No.: 14623824